Dabirix 110mg Tablet
Marketer
Fibovil Pharmaceuticals Pvt Ltd
Salt Composition
Dabigatran Etexilate (110mg)
Overview Dabirix 110mg Tablet
Coagulase 110mg tablets function as an anticoagulant, preventing and treating blood clots. This medication mitigates stroke and heart attack risk by inhibiting clot formation in leg, lung, brain, and heart veins. Frequently prescribed for individuals with atrial fibrillation to prevent thrombosis, it also lowers clot risk post-knee or hip replacement. Administration is flexible—with or without food—but consistent daily timing is recommended. Long-term, even lifelong, use may be necessary; cessation or dosage alteration requires physician approval to avoid increased stroke, heart attack, or thrombosis risk. Lifestyle modifications, including diet, exercise, smoking cessation, and weight management, further reduce clot risk. Common side effects include gastrointestinal upset and increased bleeding (e.g., nosebleeds, bruising). Report any adverse effects immediately. Other potential side effects comprise headaches, seizures, allergic reactions, visual disturbances, and fatigue. Contraindications include severe hepatic or renal impairment, active bleeding, and concurrent use of other anticoagulants. Breastfeeding is not advised during treatment. Unlike some anticoagulants, routine PT-INR monitoring isn't mandated.
Uses of Dabirix 110mg Tablet
Preventing and managing blood clots
Major Benefits of Dabirix 110mg Tablet:
Consume this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid crushing, chewing, or breaking it. Dabirix 110mg Tablets can be administered with or without food, though consistent timing is recommended.
Common Side effects of Dabirix 110mg Tablet:
- Nausea
- Anemia (low number of red blood cells)
- Gastrointestinal bleeding
- Dyspepsia
- Diarrhea
- Abdominal pain
- Nosebleeds
- Skin bleeding
How to use Dabirix 110mg Tablet:
Administer this medication precisely as prescribed by your physician, adhering to both the dosage and treatment duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Dabirix 110mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Dabirix 110mg Tablet works:
Lixaven 110mg tablets are a new generation oral blood thinner. Their mechanism of action involves inhibiting blood clot development.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol while taking Dabirix 110mg Tablet is not recommended due to safety concerns.
PregnancyCONSULT YOUR DOCTOR
Using Dabirix 110mg tablets during pregnancy might pose risks. While human data is scarce, animal studies indicate potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Use of Dabirix 110mg tablets while breastfeeding is likely inadvisable. Available evidence from human studies indicates potential transfer of the medication into breast milk, posing a risk to the infant.
DrivingSAFE
Driving ability is typically unaffected by Dabirix 110mg Tablets.
KidneyCAUTION
Exercise caution when administering Dabirix 110mg Tablets to individuals with severe renal impairment; dosage modification may be necessary. Consult a physician before use. Dabirix 110mg Tablets are contraindicated in patients exhibiting severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Dabirix 110mg tablets cautiously; dosage modification may be necessary. Physician consultation is advised.
What if you forget to take Dabirix 110mg Tablet :
Should you forget to take your Dabirix 110mg Tablet, administer it as soon as you remember, but only if it's still the same day. However, omit the missed dose if it's less than 6 hours until your next scheduled intake. Never compensate for a missed dose by taking a double dose.
Facts to Know About Dabirix 110mg Tablet
| Label | Value |
|---|---|
| Chemical Category | Benzimidazole-based compound |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Oral direct thrombin inhibitor |



